{"id":478163,"date":"2021-04-19T09:19:55","date_gmt":"2021-04-19T13:19:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/"},"modified":"2021-04-19T09:19:55","modified_gmt":"2021-04-19T13:19:55","slug":"zynex-schedules-2021-first-quarter-earnings-call","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/","title":{"rendered":"Zynex Schedules 2021 First Quarter Earnings Call"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

ENGLEWOOD,\u00a0Colo., April 19, 2021<\/span> \/PRNewswire\/ —\u00a0Zynex, Inc.<\/a>\u00a0(Nasdaq: ZYXI)<\/a>, an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company’s 2021 first quarter earnings investor webcast on\u00a0Thursday, April 29, 2021 at\u00a02:15 p.m. Mountain Time\u00a0(4:15 p.m. Eastern Time<\/span>.)<\/p>\n

\n

\n
\n \"Zynex\"
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n Webcast Details:\u00a0Thursday, April 29, 2021\u00a0at\u00a02:15 p.m. MT\u00a0\/\u00a04:15 p.m. ET<\/b>\n <\/p>\n

To register and participate in the webcast, interested parties should click on the following link or dial in approximately 10-15 minutes prior to the webcast:<\/p>\n

\n https:\/\/www.webcaster4.com\/Webcast\/Page\/1487\/40947<\/a>\n <\/p>\n

\n\n\n\n\n
\n

\n
\n US PARTICIPANT DIAL IN (TOLL FREE):<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 1-844-825-9790<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n INTERNATIONAL DIAL IN:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 1-412-317-5170<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Canada Toll Free:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 1-855-669-9657<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n About Zynex\u00a0<\/b>
\n
Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the Company’s proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex has also developed a blood volume monitor for use in hospitals and surgery centers.\u00a0 For additional information, please visit:\u00a0Zynex.com<\/a>.<\/p>\n

\n Safe Harbor Statement <\/b>
\n
This release contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. <\/p>\n

Forward-looking\u00a0statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, forecasts, anticipated events and trends, the economy and other future conditions. Because\u00a0forward-looking\u00a0statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore you should not rely on any of these forward looking statements. \u00a0The Company makes no express or implied representation or warranty as to the completeness of forward looking statements or, in the case of projections, as to their attainability or the accuracy and completeness of the assumptions from which they are derived. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain CE marking of new products, the acceptance of new products as well as existing products by doctors and hospitals, larger competitors with greater financial resources, the need to keep pace with technological changes, our dependence on the reimbursement for our products from health insurance companies, our dependence on third party manufacturers to produce our goods on time and to our specifications, implementation of our sales strategy including a strong direct sales force, the impact of COVID-19 on the global economy and other risks described in our filings with the Securities and Exchange Commission including, but not limited to our Annual Report on Form 10-K for the year ended\u00a0December 31, 2020\u00a0as well as our quarterly reports on Form 10-Q and current reports on Form 8-K.<\/p>\n

Any forward-looking statement made by us in this release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.<\/p>\n

\n Contact:<\/b>
\n
Zynex, Inc.
(800) 495-6670<\/p>\n

\n Investor Relations Contact:
<\/b>Amato and Partners, LLC
Investor Relations Counsel
admin@amatoandpartners.com<\/a><\/p>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/zynex-schedules-2021-first-quarter-earnings-call-301271075.html<\/a><\/p>\n

SOURCE Zynex<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire ENGLEWOOD,\u00a0Colo., April 19, 2021 \/PRNewswire\/ —\u00a0Zynex, Inc.\u00a0(Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company’s 2021 first quarter earnings investor webcast on\u00a0Thursday, April 29, 2021 at\u00a02:15 p.m. Mountain Time\u00a0(4:15 p.m. Eastern Time.) Webcast Details:\u00a0Thursday, April 29, 2021\u00a0at\u00a02:15 p.m. MT\u00a0\/\u00a04:15 p.m. ET To register and participate in the webcast, interested parties should click on the following link or dial in approximately 10-15 minutes prior to the webcast: https:\/\/www.webcaster4.com\/Webcast\/Page\/1487\/40947 US PARTICIPANT DIAL IN (TOLL FREE): 1-844-825-9790 INTERNATIONAL DIAL IN: 1-412-317-5170 Canada Toll Free: 1-855-669-9657 About Zynex\u00a0 Zynex, founded in 1996, markets and sells its … <\/p>\n

Continue reading “Zynex Schedules 2021 First Quarter Earnings Call”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-478163","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nZynex Schedules 2021 First Quarter Earnings Call - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zynex Schedules 2021 First Quarter Earnings Call - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire ENGLEWOOD,\u00a0Colo., April 19, 2021 \/PRNewswire\/ —\u00a0Zynex, Inc.\u00a0(Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company’s 2021 first quarter earnings investor webcast on\u00a0Thursday, April 29, 2021 at\u00a02:15 p.m. Mountain Time\u00a0(4:15 p.m. Eastern Time.) Webcast Details:\u00a0Thursday, April 29, 2021\u00a0at\u00a02:15 p.m. MT\u00a0\/\u00a04:15 p.m. ET To register and participate in the webcast, interested parties should click on the following link or dial in approximately 10-15 minutes prior to the webcast: https:\/\/www.webcaster4.com\/Webcast\/Page\/1487\/40947 US PARTICIPANT DIAL IN (TOLL FREE): 1-844-825-9790 INTERNATIONAL DIAL IN: 1-412-317-5170 Canada Toll Free: 1-855-669-9657 About Zynex\u00a0 Zynex, founded in 1996, markets and sells its … Continue reading "Zynex Schedules 2021 First Quarter Earnings Call"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-19T13:19:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/373722\/zynex_medical_vector_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zynex-schedules-2021-first-quarter-earnings-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zynex-schedules-2021-first-quarter-earnings-call\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Zynex Schedules 2021 First Quarter Earnings Call\",\"datePublished\":\"2021-04-19T13:19:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zynex-schedules-2021-first-quarter-earnings-call\\\/\"},\"wordCount\":603,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zynex-schedules-2021-first-quarter-earnings-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/373722\\\/zynex_medical_vector_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zynex-schedules-2021-first-quarter-earnings-call\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zynex-schedules-2021-first-quarter-earnings-call\\\/\",\"name\":\"Zynex Schedules 2021 First Quarter Earnings Call - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zynex-schedules-2021-first-quarter-earnings-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zynex-schedules-2021-first-quarter-earnings-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/373722\\\/zynex_medical_vector_Logo.jpg\",\"datePublished\":\"2021-04-19T13:19:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zynex-schedules-2021-first-quarter-earnings-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zynex-schedules-2021-first-quarter-earnings-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zynex-schedules-2021-first-quarter-earnings-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/373722\\\/zynex_medical_vector_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/373722\\\/zynex_medical_vector_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zynex-schedules-2021-first-quarter-earnings-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zynex Schedules 2021 First Quarter Earnings Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zynex Schedules 2021 First Quarter Earnings Call - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/","og_locale":"en_US","og_type":"article","og_title":"Zynex Schedules 2021 First Quarter Earnings Call - Market Newsdesk","og_description":"PR Newswire ENGLEWOOD,\u00a0Colo., April 19, 2021 \/PRNewswire\/ —\u00a0Zynex, Inc.\u00a0(Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company’s 2021 first quarter earnings investor webcast on\u00a0Thursday, April 29, 2021 at\u00a02:15 p.m. Mountain Time\u00a0(4:15 p.m. Eastern Time.) Webcast Details:\u00a0Thursday, April 29, 2021\u00a0at\u00a02:15 p.m. MT\u00a0\/\u00a04:15 p.m. ET To register and participate in the webcast, interested parties should click on the following link or dial in approximately 10-15 minutes prior to the webcast: https:\/\/www.webcaster4.com\/Webcast\/Page\/1487\/40947 US PARTICIPANT DIAL IN (TOLL FREE): 1-844-825-9790 INTERNATIONAL DIAL IN: 1-412-317-5170 Canada Toll Free: 1-855-669-9657 About Zynex\u00a0 Zynex, founded in 1996, markets and sells its … Continue reading \"Zynex Schedules 2021 First Quarter Earnings Call\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-19T13:19:55+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/373722\/zynex_medical_vector_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Zynex Schedules 2021 First Quarter Earnings Call","datePublished":"2021-04-19T13:19:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/"},"wordCount":603,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/373722\/zynex_medical_vector_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/","name":"Zynex Schedules 2021 First Quarter Earnings Call - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/373722\/zynex_medical_vector_Logo.jpg","datePublished":"2021-04-19T13:19:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/373722\/zynex_medical_vector_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/373722\/zynex_medical_vector_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zynex-schedules-2021-first-quarter-earnings-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Zynex Schedules 2021 First Quarter Earnings Call"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/478163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=478163"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/478163\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=478163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=478163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=478163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}